… of new artemisinin regimens should be further … to chloroquine and sulfadoxine–pyrimethamine
has required urgent introduction of alternative antimalarial therapies, including artemisinin…

… in combination with other antimalarials, such that no parasite “sees” the artemisinin component
… Even when a correct course is obtained adherence to antimalarial treatment regimens is …

… If chloroquine treatment of intercurrent vivax malaria had any significant antimalarial effect
it would have reduced late cases of recrudescence. Chloroquine did not affect cure rates …

… antimalarial agents, such as chloroquine, sulfadoxine/pyrimethamine and, more recently,
mefloquine. Since chloroquine … new combination than with the conventional dose regimen of …

… It was first used in the early 1980's when the combination of chloroquine (CQ) plus SP was
… than the addition of PQ to antimalarial regimens for reducing gametocyte carriage among P. …

… and treatment with artemisinin-based combination therapies (… vivax are mostly still treated
with chloroquine. We review the … P vivax remains sensitive to chloroquine and diagnostic tests …

… vivax parasites; artemisinin-based combinations have shorter parasite and fever clearance
times compared to chloroquine. ACT is as effective as chloroquine in preventing recurrent …

… combining an artemisinin and two existing partner drugs, could be a stop-gap therapy for
treating multidrug-resistant malaria until new antimalarials … artemisinins from other antimalarials…

… antimalarials (typically chloroquine or sulphadoxine–pyrimethamine) towards the adoption of
artemisinin-based combination … as a 3-day combination regimen. The main clinical benefits …

… adherence to ACT regimens was not consistent. … anti-malarials were used by patients [10].
As this review was undertaken in the infancy of the ACT era, two studies looked at artemisinin …